HGSC is a member of The Cancer Genome Atlas project, an ambitious government-funded consortium created to identify cancer-causing genes. The Dan L. Duncan Cancer Center, which conducted all tissue banking for the samples, provided this update in its 2015 annual report, which highlights the work that led to sequencing tumors of the pancreas, colon, kidney, breast and bladder.
The sequence and analysis of the gibbon genome was published today in the journal Nature and led by scientists at Oregon Health & Science University, the Baylor College of Medicine Human Genome Sequencing Center and the Washington University School of Medicine’s Genome Institute.
Image courtesy of Nature Publishing Group
|Image source: Sang Eun Lee, Samsung Medical Center|
Researchers in The Cancer Genome Atlas (TCGA) Network have made a number of new findings about the biology and development of a rare form of kidney cancer.
Dr. Caleb Davis and Dr. Min Wang of the BCM-HGSC are co-first authors on the paper, The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma, which appeared August 21, 2014 in Cancer Cell.
The development and clinical implementation of the Whole Exome Sequencing test derives from a joint effort by Baylor's Human Genome Sequencing Center and Baylor Miraca Genetics Laboratories to establish a clinical laboratory dedicated to state-of-the-art next generation sequencing.